Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
One of the most common adverse effects resulting from the therapy with thiazides,
thiazide-like diuretics and loop diuretics is increased potassium secretion. Disregulation of
plasma potassium may be a life-threatening condition due to increased risk of arrythmias.
Moreover, it has been postulated that decrease in plasma potassium level may negatively
affect glucose metabolism resulting in the increased risk of new-onset type 2 diabetes.The
main goal of this study is to assess the efficacy and safety of
telmisartan/hydrochlorothiazide in a broad population of hypertensive patients, including the
effects of the therapy on plasma potassium level and also on selected parameters of glucose
and lipid metabolism.
Details
Lead Sponsor:
Bayer
Treatments:
Hydrochlorothiazide Telmisartan Telmisartan, hydrochlorothiazide drug combination